Paclitaxel Liposomal Suppliers & Bulk Manufacturers

Available Forms: Injection (IV administration)

Available Strengths: 30 mg/5 mL, 100 mg/16.7 mL, 300 mg/50 mL

Reference Brands: Taxol®, Abraxane® (US & EU)

Category: Oncology Cancer Care

Paclitaxel (brands Taxol® and Abraxane®) is an essential chemotherapy agent used for breast, ovarian, and lung cancer. Available in IV injection forms, with strengths like 30 mg/5 mL, 100 mg/16.7 mL, and 300 mg/50 mL, Paclitaxel stabilizes microtubules to halt cancer cell division. Sourced globally by B2B pharma suppliers, it is GMP-compliant and widely available in the US and EU. Paclitaxel liposomal is available in Injection (IV administration) and strengths such as 30 mg/5 mL, 100 mg/16.7 mL, 300 mg/50 mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Paclitaxel liposomal is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Paclitaxel liposomal can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description:

Paclitaxel, marketed as Taxol® and Abraxane®, is a critical chemotherapy agent used to treat various cancers, including ovarian, breast, and lung cancer. Available in IV injection forms, with strengths like 30 mg/5 mL, 100 mg/16.7 mL, and 300 mg/50 mL, Paclitaxel works by stabilizing microtubules to prevent cell division. Widely sourced by B2B pharmaceutical suppliers globally, Paclitaxel ensures GMP-compliant manufacturing and reliable supply to hospitals and oncology centers in the US and EU. With competitive pricing, it is a vital component in cancer treatment regimens, providing effective therapy for aggressive cancers.